Court Approves Settlement With Aytu BioPharma Inc.
The Delaware Court of Chancery approved a class settlement of claims against Aytu BioPharma Inc. and directors relating to affiliated transactions and trading.
Read moreThe Delaware Court of Chancery approved a class settlement of claims against Aytu BioPharma Inc. and directors relating to affiliated transactions and trading.
Read moreA running log of legal and regulatory developments in the world of closed end funds packaged with unsolicited and (sometimes) insightful pro-investor commentary.
Read moreLead plaintiff ATG Fund II LLC has filed for final approval of a $7 million settlement of claims arising from the liquidation of VPC Impact Acquisition Holdings II, a special purpose acquisition company.
Read moreAaron Morris submitted a written comment to the Securities & Exchange Commission in connection with an ill-conceived proposal to exempt closed-end funds from the annual shareholder meeting requirement.
Read moreMorris Kandinov LLP obtains final approval of settlement arising from closed-end fund collapse.
Read moreThe District Court in the Pioneer Merger Corp. litigation has authorized the distribution of the net settlement fund to investors.
Read moreMorris Kandinov LLP, on behalf of the lead plaintiff, filed motions for final approval and for reimbursement of fees and expenses in connection with SPAC settlement.
Read moreDelaware Chancery Court ruling permits interim distribution of remaining trust funds while litigation over broken transaction proceeds.
Read moreThe Delaware Chancery Court upheld claims for breach of fiduciary duty and wrongful dilution arising from a proxy contest in 2023.
Read moreBulldog Investors, LLP retains Morris Kandinov LLP in declaratory judgment action against bankruptcy trustee seeking the return of trust funds properly distributed to stockholders.
Read more